INVO Bioscience Inc (INVO)
0.884
-0.04
(-4.42%)
USD |
NASDAQ |
May 06, 14:12
INVO Bioscience Cash from Financing (TTM): 7.392M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 7.392M |
September 30, 2023 | 8.334M |
June 30, 2023 | 3.86M |
March 31, 2023 | 4.030M |
December 31, 2022 | 1.090M |
September 30, 2022 | 3.690M |
June 30, 2022 | 3.716M |
March 31, 2022 | 3.716M |
December 31, 2021 | 3.770M |
September 30, 2021 | 11.48M |
June 30, 2021 | 11.88M |
March 31, 2021 | 14.19M |
December 31, 2020 | 13.82M |
September 30, 2020 | 2.715M |
June 30, 2020 | 2.274M |
March 31, 2020 | -0.035M |
December 31, 2019 | -0.2295M |
September 30, 2019 | -0.2595M |
June 30, 2019 | -0.2796M |
March 31, 2019 | 0.6174M |
December 31, 2018 | 0.8589M |
September 30, 2018 | 0.8989M |
June 30, 2018 | 0.9986M |
March 31, 2018 | 0.1016M |
December 31, 2017 | 0.0546M |
Date | Value |
---|---|
September 30, 2017 | 0.0446M |
June 30, 2017 | 0.00 |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 0.625M |
September 30, 2015 | 0.0969M |
June 30, 2015 | 0.0877M |
March 31, 2015 | 0.0749M |
December 31, 2011 | 0.1057M |
September 30, 2011 | 0.0417M |
June 30, 2011 | 0.1405M |
March 31, 2011 | 0.1982M |
December 31, 2010 | 0.2495M |
September 30, 2010 | 0.4995M |
June 30, 2010 | 0.8689M |
March 31, 2010 | 0.822M |
December 31, 2009 | 0.99M |
September 30, 2009 | 1.996M |
June 30, 2009 | 1.322M |
March 31, 2009 | 1.424M |
December 31, 2008 | 1.156M |
September 30, 2008 | 0.013M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.2796M
Minimum
Jun 2019
14.19M
Maximum
Mar 2021
5.008M
Average
3.716M
Median
Mar 2022
Cash from Financing (TTM) Benchmarks
Abbott Laboratories | -7.091B |
Perspective Therapeutics Inc | 0.785M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Catheter Precision Inc | 8.386M |